Evidence map›Paper›PMID 26833087›Full record

ArticleMolecular cell2016

Antisense Transcripts Delimit Exonucleolytic Activity of the Mitochondrial 3' Processome to Generate Guide RNAs.

Takuma Suematsu, Liye Zhang, Inna Aphasizheva, Stefano Monti, Lan Huang, Qi Wang, Catherine E Costello, Ruslan Aphasizhev

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mitochondrial RNA quality control in trypanosomes.Wiley interdisciplinary reviews. RNA · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takuma SuematsuDepartment of Molecular and Cell Biology, Boston University School of Dental Medicine, Boston, MA 02118, USA.
Liye ZhangSection of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA.
Inna AphasizhevaDepartment of Molecular and Cell Biology, Boston University School of Dental Medicine, Boston, MA 02118, USA.
Stefano MontiSection of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA.
Lan HuangDepartment of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Qi WangDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
Catherine E CostelloDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
Ruslan AphasizhevDepartment of Molecular and Cell Biology, Boston University School of Dental Medicine, Boston, MA 02118, USA; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: ruslana@bu.edu.
Boston University · USUniversity of California, Irvine · US

Funding

Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
Proteomics of the Proteasome Interacting NetworksR01GM074830 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, LAN · 2005 to 2022
$6.1M
Guide RNA Binding ComplexR01AI101057 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Ruslan Afasizhev · 2012 to 2026
$6.0M
Structures and Functions of RNA Editing TUTasesR01AI091914 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI AFASIZHEV, RUSLAN · 2011 to 2020
$4.4M
RNA Uridylytransferases of TrypanosomesR01AI064653 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI AFASIZHEV, RUSLAN · 2005 to 2009
$1.8M
NIAID NIH HHS AI091914NIAID NIH HHS AI101057NIAID NIH HHS R01 AI064653NIAID NIH HHS R01 AI091914NIAID NIH HHS R01 AI101057NIGMS NIH HHS GM074830NIGMS NIH HHS P41 GM104603NIGMS NIH HHS R01 GM074830
6 · The paper itself

Abstract

Small, noncoding RNA biogenesis typically involves cleavage of structured precursor by RNase III-like endonucleases. However, guide RNAs (gRNAs) that direct U-insertion/deletion mRNA editing in mitochondria of trypanosomes maintain 5' triphosphate characteristic of the transcription initiation and possess a U-tail indicative of 3' processing and uridylation. Here, we identified a protein complex composed of RET1 TUTase, DSS1 3'-5' exonuclease, and three additional subunits. This complex, termed mitochondrial 3' processome (MPsome), is responsible for primary uridylation of ∼800 nt gRNA precursors, their processive degradation to a mature size of 40-60 nt, and secondary U-tail addition. Both strands of the gRNA gene are transcribed into sense and antisense precursors of similar lengths. Head-to-head hybridization of these transcripts blocks symmetrical 3'-5' degradation at a fixed distance from the double-stranded region. Together, our findings suggest a model in which gRNA is derived from the 5' extremity of a primary molecule by uridylation-induced, antisense transcription-controlled 3'-5' exonucleolytic degradation.

Indexed as

RNA EditingExoribonucleasesGene Expression RegulationMitochondriaProtozoan ProteinsRNARNA, AntisenseRNA, Guide, KinetoplastidaRNA, MitochondrialRNA NucleotidyltransferasesRNA, ProtozoanRNA StabilityTime FactorsTrypanosoma brucei bruceiUracil NucleotidesExoribonucleasesProtozoan ProteinsRNARNA, AntisenseRNA, Guide, KinetoplastidaRNA, MitochondrialRNA NucleotidyltransferasesRNA, ProtozoanUracil Nucleotidesexonucleaseguide RNAmitochondriaRNA decayRNA editingtrypanosomaTUTase

Identifiers

PMID26833087
PMCPMC4744118
OpenAlexW2270903458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.